Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kanfer

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Haematologica|June 28, 2000
Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilizationE Olavarria, S Parker, C Craddock, et al.
Bone Marrow Transplantation|March 7, 2003
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patientsE Terpos, J F Apperley, D Samson, et al.
Leukemia|June 25, 2004
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myelomaE Terpos, M Politou, R Szydlo, et al.
Bone Marrow Transplantation|October 19, 2001
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsK Cwynarski, R Goulding, C Pocock, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell doseC Pocock, R Szydlo, J Davis, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Blood|December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemiaF Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology|February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxisC Craddock, R M Szydlo, F Dazzi, et al.
Bone Marrow Transplantation|March 10, 2015
Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working PartyK Horstmann, A Boumendil, J Finke, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Haematologica|June 28, 2000
Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilizationE Olavarria, S Parker, C Craddock, et al.
Bone Marrow Transplantation|March 7, 2003
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patientsE Terpos, J F Apperley, D Samson, et al.
Leukemia|June 25, 2004
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myelomaE Terpos, M Politou, R Szydlo, et al.
Bone Marrow Transplantation|October 19, 2001
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsK Cwynarski, R Goulding, C Pocock, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Stem cell transplantation for chronic myeloid leukaemia: the role of infused marrow cell doseC Pocock, R Szydlo, J Davis, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Blood|December 23, 1999
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemiaF Dazzi, R M Szydlo, C Craddock, et al.
British Journal of Haematology|February 13, 2001
Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxisC Craddock, R M Szydlo, F Dazzi, et al.
Bone Marrow Transplantation|March 10, 2015
Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working PartyK Horstmann, A Boumendil, J Finke, et al.
Pageof 4